Blog
Insights on using AI to search for the cure of cancer

Stand Up To Cancer Expands Its Scientific Advisory Committee: A Step Forward in Cancer Research
August 3, 2026
On August 3, 2026, Stand Up To Cancer (SU2C) announced the addition of new members to its Scientific Advisory Committee, a move that underscores the organization's commitment to advancing cancer...
Read more →
At Cure Cancer With AI , our mission is to empower individuals with the latest information on cancer research, AI advancements in oncology, and updates on clinical trials. We believe that informed...
Read more →
In a significant stride towards advancing cancer research and treatment, Stand Up To Cancer (SU2C) has recently expanded its Scientific Advisory Committee by adding new members. This development is...
Read more →
At Cure Cancer With AI , we believe that knowledge is power. By staying informed about the latest advancements in cancer research, artificial intelligence in oncology, and ongoing clinical trials, we...
Read more →
UCSF Researcher Awarded IGNITE Fellowship: A Step Forward in Immune-Based Cancer Therapy
August 3, 2026
In an exciting development in the field of oncology, Dr. Adam Blaisdell from UCSF Health has been awarded the prestigious IGNITE fellowship by the Cancer Research Institute (CRI). This honor not only...
Read more →
Recent research from the Wistar Institute has unveiled a surprising relationship between fructose, a common sugar found in fruits and sweetened beverages, and the spread of aggressive ovarian cancer....
Read more →
Lung cancer remains a significant public health crisis, with 2022 statistics revealing that approximately 1.8 million individuals succumbed to the disease worldwide, and around 2.5 million new...
Read more →
At Cure Cancer With AI , our mission is to empower individuals with the latest information and resources about cancer research, clinical trials, and oncology developments. By shopping at our official...
Read more →
The MAMMAL Drug-Target Interaction API , part of the free Cure Cancer With AI public API , offers a powerful solution for predicting drug-target binding affinities. Specifically, it allows developers...
Read more →
Global Call for Equitable Lung Cancer Screening: The Role of AI in Transforming Early Detection and Treatment
August 3, 2026
Lung cancer continues to be a pressing public health issue, with the World Health Organization reporting approximately 1.8 million deaths attributable to the disease in 2022. This staggering...
Read more →
New Insights into Rapid-Acting Antidepressants: Implications for Cancer Patients and the Role of AI in Treatment Innovation
August 2, 2026
Researchers at The University of Texas MD Anderson Cancer Center recently unveiled important findings regarding rapid-acting antidepressants such as ketamine and certain psychedelics. These...
Read more →
Cancer is a complex and multifaceted disease that affects millions of people worldwide. As research progresses, it becomes increasingly challenging to keep track of the latest findings, clinical...
Read more →
New Insights into Rapid-Acting Antidepressants: Implications for Cancer Patients and Research
August 2, 2026
Recent research from The University of Texas MD Anderson Cancer Center has shed light on how certain fast-acting antidepressants, such as ketamine and psychedelics, can provide relief for individuals...
Read more →
Support Cancer Research and Awareness by Shopping Official Cure Cancer With AI Products
August 2, 2026
At Cure Cancer With AI , our mission is to empower individuals with knowledge about cancer research, AI advancements in oncology, clinical trials, and the latest cancer news. We believe that informed...
Read more →
Exploring Bloom Syndrome: New Research Insights and the Role of AI in Cancer Treatment
August 2, 2026
In a significant advancement for understanding rare genetic conditions, the Bloom Syndrome Association (BSA) and the National Organization for Rare Disorders (NORD) have launched a comprehensive...
Read more →
The recent launch of a natural history study by the Bloom Syndrome Association (BSA) and the National Organization for Rare Disorders (NORD) marks a significant step forward in our understanding of...
Read more →
At Cure Cancer With AI, we are excited to announce the availability of IBM's MAMMAL (Molecular Aligned Multi-Modal Architecture and Language) biomedical foundation model through our free public API....
Read more →
Enhancing Diversity in Pediatric Oncology Clinical Trials: A Step Toward Equitable Cancer Research
August 2, 2026
The recent study from UT Southwestern Medical Center, published in JAMA Network Open, sheds light on a significant yet often overlooked issue in pediatric cancer research: the underrepresentation of...
Read more →
The MAMMAL Protein–Protein Interaction API is a powerful resource within the free Cure Cancer With AI API . This endpoint enables developers to predict the binding-affinity class for two proteins...
Read more →
Navigating the complex world of cancer research and treatment can often feel overwhelming. With rapid advancements in oncology, it’s crucial for patients, caregivers, and advocates to have access to...
Read more →